natgillin/translations-raw huggingface dataset:
Official and local antimicrobial policies should be taken into account when the product is used.
Službeni i lokalni antimikrobni propisi trebali bi se uzeti u obzir kada se koristi veterinarskomedicinski proizvod.
Resistance to fluoroquinolones has been reported to arise from five sources, (i) point mutations in the genes encoding for DNA gyrase and/or topoisomerase IV leading to alterations of the respective enzyme, (ii) alterations of drug permeability in Gram-negative bacteria, (iii) efflux mechanisms, (iv) plasmid mediated resistance and (v) gyrase protecting proteins.
Otpornost na fluorokinolone zabilježena je da proizlazi iz pet izvorišta, (i) točke mutacije na genima koji kodiraju DNA girazu i/ili topoizomerazu IV, što dovodi do promjena dotičnih enzima, (ii) promjene permeabilnosti kod Gram-negativnih bakterija, (iii) protočni mehanizmi, (iv) otpornost posredovana plazmidima i ( v) proteini čuvari giraze.
Amberlite IRP 64 Sorbic acid Ascorbic acid Xanthan gum Propylene glycol Vanilla flavour Purified water
Sorbinska kiselina Askorbinska kiselina Ksantanska guma Propilen glikol Aroma vanilije Pročišćena voda
Ask your veterinarian for advice if no improvement of the clinical condition is observed within 3 days after starting the treatment.
Pitajte svog veterinara za savjet ako se ne uočava poboljšanje kliničkog stanja u roku 3 dana od početka liječenja.
Bodyweight of Cat (kg)
Tjelesna masa mačke (kg)
The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated-) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Učestalost nuspojava je određena sukladno sljedećim pravilima: - vrlo česte (više od 1 na 10 tretiranih životinja pokazuju nuspojavu(e)) - česte (više od 1 ali manje od 10 životinja na 100 tretiranih životinja) - manje česte (više od 1 ali manje od 10 životinja na 1.000 tretiranih životinja) - rijetke (više od 1 ali manje od 10 životinja na 10.000 tretiranih životinja) - vrlo rijetke (manje od 1 životinje na 10.000 tretiranih životinja, uključujući izolirane slučajeve).
PL-02-326 Warszawa Tel: +48 22 572 35 00
Jerozolimskie 158 PL-02-326 Warszawa Tel: +48 22 572 35 00
Manufacturer responsible for batch release: KVP Pharma +Veterinär Produkte GmbH Projensdorfer Str. 324
Proizvođač odgovoran za puštanje serije u promet: KVP Pharma + Veterinär Produkte GmbH Projensdorfer Str. 324
Pradofloxacin dose (mg/kg bw)
Doza pradofloksacina (mg/kg bw)
MIC range (µg/ml)
MIC raspon (µg/ml)
Further, fluoroquinolones should not be used in combination with non-steroidal anti-inflammatory drugs (NSAIDs) in animals with a history of seizures because of potential pharmacodynamic interactions in the CNS.
Nadalje, fluorokinoloni se ne bi smjeli primjenjivati u kombinaciji sa nesteroidnim protuupalnim lijekovima (NSPUL) kod životinja koje u anamnezi imaju napadaje zbog potencijalno farmakodinamičkih interakcija u središnjem živčanom sustavu.
Pradofloxacin is eliminated from serum with a terminal half-life of 9 hours.
Pradofloksacin se eliminira iz seruma s krajnjim poluvremenom od 9 sati.
Folding carton containing 30 ml white high density polyethylene (HDPE) bottle with a polyethylene adapter and a child-resistant closure.
Sklopiva kartonska kutija s bijelom bočicom 30 ml od polietilena (HDPE) s polietilenskim adapterom i sigurnosnim zatvaračem.
Excretion via kidneys is an important elimination route for pradofloxacin in dogs and, therefore, pradofloxacin should be used with caution in animals with impaired kidney function.
Izlučivanje preko bubrega je važan put eliminacije pradofloksacina kod pasa, stoga pradofloksacin treba primjenjivati oprezno kod životinja s oštećenom bubrežnom funkcijom.
Pradofloxacin is eliminated from serum with a terminal half-life of 7 hours.
Pradofloksacin se eliminira iz seruma s krajnjim poluvremenom od 7 sati.
Repeated dosing shows no impact on the pharmacokinetic profile, (accumulation index = 1.2).
Ponovljena aplikacija ne pokazuje utjecaj na farmakokinetički profil (indeks akumulacije= 1,2).
The treatment should be re-considered if no improvement of the clinical conditions is observed within 3 days, or in cases of superficial pyoderma 7 days, and in cases of deep pyoderma 14 days, after starting the treatment.
Liječenje bi trebalo iznova razmotriti ako se ne uoči poboljšanje kliničkog stanja u roku 3 dana, ili u slučaju površinske pioderme 7 dana, te u slučajevima duboke pioderme 14 dana, od početka liječenja.
Therefore, Veraflox should not be administered concurrently with antacids, sucralfate, multivitamins or dairy products, as absorption of Veraflox may be decreased.
Stoga, Veraflox se ne bi trebao primjenjivati istovremeno s antacidima, sukralfatom, multivitaminima ili mliječnim proizvodima, jer apsorpcija Verafloxa može biti smanjena.
Veraflox should not be administered concurrently with antacids or sucralfate (used for gastric acidity), multivitamins or dairy products, as the absorption of Veraflox may be decreased.
Veraflox se ne bi trebao primjenjivati istovremeno s antacidima ili sukralfatom (za kiselinu u želucu), multivitaminima ili mliječnim proizvodima, jer apsorpcija verafloxa može biti smanjena.
In cats, absorption of orally administered pradofloxacin at the therapeutic dose is rapid reaching peak concentrations of 1.2 mg/l within 0.5 hours.
Kod mačaka, apsorpcija peroralno apliciranog pradofloksacina u terapijskoj dozi je brza i doseže vrhunac koncentracije od 1,2 mg/l u roku 0,5 sati.
After oral administration of the veterinary medicinal product to cats at the recommended therapeutic dose, absorption of pradofloxacin is rapid, reaching peak concentrations of 2.1 mg/l within 1 hour.
Nakon peroralne aplikacije veterinarsko medicinskog proizvoda kod mačaka u terapijskoj dozi, apsorpcija pradofloksacina je brza i doseže vrhunac koncentracije od 2,1 mg/l u roku 1 sata.
4.2 Indications for use, specifying the target species Dogs:
4.2 Indikacije za primjenu, navesti ciljne vrste životinja
Folding carton containing 15 ml white high density polyethylene (HDPE) bottle with a polyethylene adapter and a child-resistant closure and a 3 ml polypropylene oral dosing syringe (graduation: 0.1 to 2 ml).
Sklopiva kartonska kutija s bijelom bočicom od 15 ml od polietilena visoke gustoće HDPE) s polietilenskim adapterom i sigurnosnim zatvaračem te 3 ml polipropilenskom špricom za peroralno doziranje (graduacija:0,1 do 2 ml).
QUANTITY OF THE ACTIVE SUBSTANCE(S) Pradofloxacin 25 mg/ml
KOLIČINA DJELATNE(IH) TVARI Pradofloksacin 25 mg/ml
In laboratory studies the bioavailability of pradofloxacin was reduced in fed dogs and cats compared to fasted animals.
U laboratorijskim pokusima bioraspoloživost pradofloksacina smanjena je kod nahranjenih pasa i mačaka u usporedbi s gladnim.
• as adjunctive treatment to mechanical or surgical periodontal therapy in the treatment of severe infections of the gingiva and periodontal tissues caused by susceptible strains of anaerobic organisms, for example Porphyromonas spp.
• Kao dopunska terapija u mehaničkoj ili kirurškoj periodontalnoj terapiji u liječenju teških infekcija gingive i periodontalnih tkiva uzrokovanih osjetljivim sojevima anaerobnih organizama, na primjer Porphyromonas spp. i Prevotella spp. (vidi odjeljak 4.5).
Due to the lack of data, pradofloxacin should not be used in kittens aged less than 6 weeks.
Uslijed nedostatka podataka, pradofloksacin se ne bi trebao primjenjivati kod mačića mlađih od 6 tjedana.
Do not use in dogs during the period of growth as developing articular cartilage may be affected.
Ne primjenjivati kod pasa tijekom razdoblja rasta jer može utjecati na razvoj zglobne hrskavice.
Major elimination pathways are glucuronidation as well as renal excretion.
Glavni putevi eliminacije su glukuronidacija kao i izlučivanje bubrezima.
Due to potential harmful effects, the tablets must be kept out of the sight and reach of children.
Uslijed potencijalno štetnog djelovanja, tablete je potrebno držati dalje od pogleda i dosega djece.
No specific antidotes for pradofloxacin (or other fluoroquinolones) are known; therefore, in case of overdose symptomatic treatment should be given.
Nema specifičnog antidota za pradofloksacin (ili druge fluorokinolone); stoga , u slučaju predoziranja treba primijeniti simptomatsku terapiju.
Infrequent vomiting was observed in cats after repeated oral administration of 2.7 times the maximum recommended dose.
Rijetko povraćanje uočeno je kod mačaka nakon ponavljane peroralne primjene doze 2,7 puta veće od maksimalne preporučene doze.
Avoid skin and eye contact with the veterinary medicinal product.
Potrebno je izbjegavati doticaj veterinarsko medicinskog proizvoda s kožom i očima.
Mild transient gastro-intestinal disturbances including vomiting have been observed in rare cases.
Blagi, prolazni gastrointestinalni poremećaji, uključujući povraćanje uočeni su u rijetkim slučajevima.
Mild transient gastro-intestinal disturbances including vomiting have been observed in rare cases in dogs and cats.
Blagi, prolazni gastrointestinalni poremećaji, uključujući povraćanje uočeni su u rijetkim slučajevima kod pasa i mačaka.
Intermittent vomiting and soft faeces were observed in dogs after repeated oral administration of 2.7 times the maximum recommended dose.
Isprekidano povraćanje i mekan izmet uočeni su kod pasa nakon ponavljane peroralne primjene doze 2,7 puta veće od maksimalne preporučene doze.
In laboratory studies the bioavailability of pradofloxacin was reduced in fed cats compared to fasted animals.
U laboratorijskim pokusima bioraspoloživost pradofloksacina smanjena je kod nahranjenih mačaka u usporedbi s gladnim.
Acute infections of the upper respiratory tract
Akutne infekcije gornjih dišnih prohoda
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Folding carton containing a HDPE bottle (15 ml oral suspension)
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU Sklopiva kartonska kutija koja sadrži HDPE bočicu (15 ml peroralna suspenzija)
EXPIRY DATE EXP {month/year} Once opened, use within 3 months.
Jednom otvoreno primijeniti u roku 3 mjeseca.
Intermittent vomiting was observed after repeated oral administration of 1.6 times the maximum recommended dose.
Isprekidano povraćanje uočeno je nakon ponavljane peroralne primjene doze 1,6 puta veće od maksimalne preporučene doze.
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Folding carton containing a HDPE bottle (30 ml oral suspension)
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU Sklopiva kartonska kutija koja sadrži HDPE bočicu (30 ml peroralna suspenzija)
EU/2/10/107/005 7 tablets EU/2/10/107/006 21 tablets EU/2/10/107/007 70 tablets EU/2/10/107/008 140 tablets
EU/2/10/107/005 7 tableta EU/2/10/107/006 21 tableta EU/2/10/107/007 70 tableta EU/2/10/107/008 140 tableta
No specific antidotes for pradofloxacin (or other fluoroquinolones) are known, therefore, in case of overdose, symptomatic treatment should be given.
Specifični antidot za pradofloksacin (ili druge fluorokinolone) nije poznat, stoga, u slučaju predoziranja, potrebno je primijeniti simptomatsko liječenje.
Due to potential harmful effects, the bottle and the filled syringes must be kept out of the sight and reach of children.
Uslijed potencijalno štetnog djelovanja, bočicu i napunjene šprice potrebno je držati dalje od pogleda i dosega djece.
The recommended dose is 5 mg/kg bodyweight of pradofloxacin once daily.
Preporučena doza iznosi 5 mg/kg tjelesne mase pradofloksacina jednom dnevno.
PACKAGE LEAFLET: Veraflox 60 mg and 120 mg tablets for dogs
UPUTA O VMP: Veraflox 60 mg i 120 mg tablete za pse
EU/2/10/107/009 7 tablets EU/2/10/107/010 21 tablets EU/2/10/107/011 70 tablets EU/2/10/107/012 140 tablets
EU/2/10/107/009 7 tableta EU/2/10/107/010 21 tableta EU/2/10/107/011 70 tableta EU/2/10/107/012 140 tableta
Yellowish to beige suspension.
OBLIK Peroralna suspenzija Žućkasta do bež suspenzija.
EU/2/10/107/001 7 tablets EU/2/10/107/002 21 tablets EU/2/10/107/003 70 tablets EU/2/10/107/004 140 tablets
EU/2/10/107/001 7 tableta EU/2/10/107/002 21 tableta EU/2/10/107/003 70 tableta EU/2/10/107/004 140 tableta
STATEMENT OF ACTIVE SUBSTANCE(S) Pradofloxacin 25 mg/ml Preservative: Sorbic acid (E200)
SASTAV DJELATNIH TVARI Pradofloksacin 25 mg/ml Konzervans: sorbinska kiselina (E200)
Wound infections and abscesses Acute infections of the upper respiratory tract
Infekcije rana i apscesi Akutne infekcije gornjih dišnih prohoda
Pradofloxacin is cleared from the body at 0.24 l/h/kg.
Pradofloksacin je uklonjen iz tijela 0,24 l/h/kg.
Animal Health Drammensveien 288 NO-0283 Oslo Tlf: +47 23130500
Animal Health Drammensveien 147 B NO-0277 Oslo Tlf: +47 24 11 18 00
Brownish single-scored tablets with “P15” on one side The tablet can be divided into equal doses.
Smećkaste tablete s jednom razdjelnom linijom i „P15“ s jedne strane Tableta se može podijeliti na jednake doze.
PACKAGE LEAFLET: Veraflox 15 mg tablets for dogs and cats
UPUTA O VMP: Veraflox 15 mg tablete za pse i mačke
CONTRAINDICATIONS Do not use in cases of hypersensitivity to the active substances or to any of the excipients.
KONTRAINDIKACIJE Ne primjenjivati u slučaju preosjetljivosti na djelatne tvari ili na bilo koju od pomoćnih tvari.
Staphylococcus intermedius group (including S. pseudintermedius) Escherichia coli
Staphylococcus intermedius skupina (uključujući S. pseudintermedius) Escherichia coli
Marketing authorisation holder : Bayer Animal Health GmbH D-51368 Leverkusen Germany
Nositelj odobrenja za stavljanje u promet: Bayer Animal Health GmbH D-51368 Leverkusen Njemačka
Pradofloxacin is cleared from the body at 0.28 l/h/kg.
Pradofloksacin je uklonjen iz tijela 0,28 l/h/kg.
Brownish single-scored tablets with “P15” on one side Brownish single-scored tablets with “P60” on one side Brownish single-scored tablets with “P120” on one side The tablet can be divided into equal doses.
Smećkaste tablete s jednom razdjelnom linijom i „P15“ na jednoj strani Smećkaste tablete s jednom razdjelnom linijom i „P60“ na jednoj strani Smećkaste tablete s jednom razdjelnom linijom i „P120“ na jednoj strani Tableta se može podijeliti na jednake doze.
• superficial and deep pyoderma caused by susceptible strains of the Staphylococcus intermedius group (including S. pseudintermedius),
• Površinska i duboka pioderma uzrokovana osjetljivim sojevima iz skupine Staphylococcus intermedius (uključujući S. pseudintermedius),
Do not use in dogs during pregnancy and lactation (see section “Special Warnings”).
Ne primjenjivati kod pasa tijekom gravidnosti i laktacije (vidi odjeljak“Posebna Upozorenja“).
Brownish single-scored tablets with “P60” on one side Brownish single-scored tablets with “P120” on one side The tablet can be divided into equal doses.
Smećkaste tablete s jednom razdjelnom linijom i „P60“ s jedne strane Smećkaste tablete s jednom razdjelnom linijom i „P120“ s jedne strane Tableta se može podijeliti na jednake doze.
PACKAGE LEAFLET: Veraflox 25 mg/ml oral suspension for cats
UPUTA O VMP: Veraflox 25 mg/ml peroralna suspenzija za mačke
The treatment should be re-considered if no improvement of the clinical condition is observed within 3 days after starting the treatment.
Liječenje bi trebalo iznova razmotriti ako se ne uoči poboljšanje kliničkog stanja u roku 3 dana od početka liječenja.
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Folding carton containing 1 blister strip (1 x 7 tablets of 120 mg) Folding carton containing 3 blister strips (3 x 7 tablets of 120 mg) Folding carton containing 10 blister strips (10 x 7 tablets of 120 mg) Folding carton containing 20 blister strips (20 x 7 tablets of 120 mg)
Sklopiva kartonska kutija sadrži 1 blister traku (1 x 7 tableta od 120 mg) Sklopiva kartonska kutija sadrži 3 blister trake ( 3 x 7 tableta od 120 mg) Sklopiva kartonska kutija sadrži 10 blister traka (10 x 7 tableta od 120 mg) Sklopiva kartonska kutija sadrži 20 blister traka (20 x 7 tableta od 120 mg)
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Folding carton containing 1 blister strip (1 x 7 tablets of 60 mg) Folding carton containing 3 blister strips (3 x 7 tablets of 60 mg) Folding carton containing 10 blister strips (10 x 7 tablets of 60 mg) Folding carton containing 20 blister strips (20 x 7 tablets of 60 mg)
Sklopiva kartonska kutija sadrži 1 blister traku (1 x 7 tableta od 60 mg) Sklopiva kartonska kutija sadrži 3 blister trake ( 3 x 7 tableta od 60 mg) Sklopiva kartonska kutija sadrži 10 blister traka (10 x 7 tableta od 60 mg) Sklopiva kartonska kutija sadrži 20 blister traka (20 x 7 tableta od 60 mg)
Do not use in cats during pregnancy and lactation (see section “Special Warnings”).
Ne primjenjivati kod mačaka tijekom gravidnosti i laktacije (vidi odjeljak “Posebna Upozorenja“).
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Aluminium blister of 7 tablets (120 mg)
OSNOVNI PODACI KOJI SE MORAJU NALAZITI NA BLISTERIMA ILI TRAKAMA Aluminijski blister (120 mg)
The safety of this veterinary medicinal product has not been established during pregnancy and lactation in cats and dogs.
Neškodljivost veterinarsko-medicinskog proizvoda nije utvrđena za vrijeme graviditeta i laktacije kod kuja i mačaka.
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Folding carton containing 1 blister strip (1 x 7 tablets of 15 mg) Folding carton containing 3 blister strips (3 x 7 tablets of 15 mg) Folding carton containing 10 blister strips (10 x 7 tablets of 15 mg) Folding carton containing 20 blister strips (20 x 7 tablets of 15 mg)
Sklopiva kartonska kutija sadrži 1 blister traku (1 x 7 tableta od 15 mg) Sklopiva kartonska kutija sadrži 3 blister trake ( 3 x 7 tableta od 15 mg) Sklopiva kartonska kutija sadrži 10 blister traka (10 x 7 tableta od 15 mg) Sklopiva kartonska kutija sadrži 20 blister traka (20 x 7 tableta od 15 mg)
SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS , IF ANY
13. POSEBNE MJERE OPREZA PRILIKOM ODLAGANJA NEUPOTREBLJENOG PROIZVODA ILI OTPADNIH MATERIJALA, AKO IH IMA
NAME OF THE VETERINARY MEDICINAL PRODUCT Veraflox 25 mg/ml oral suspension for cats pradofloxacin
NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA Veraflox 25 mg/ml peroralna suspenzija za mačke pradofloksacin
Use of the veterinary medicinal product deviating from instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other fluoroquinolones due to the potential for cross-resistance.
Primjena veterinarsko medicinskih proizvoda koja odstupa od uputa danih u SPC može povećati prevalenciju bakterija otpornih na fluorokinolone i može smanjiti djelotvornost liječenja s drugim fluorokinolonima uslijed potencijalne unakrsne otpornosti.
STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 120 mg pradofloxacin.
SASTAV DJELATNIH TVARI Svaka tableta sadrži 120 mg pradofloksacina.
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Aluminium blister of 7 tablets (60 mg)
OSNOVNI PODACI KOJI SE MORAJU NALAZITI NA BLISTERIMA ILI TRAKAMA Aluminijski blister (60 mg)
NAME OF THE VETERINARY MEDICINAL PRODUCT Veraflox 25 mg/ml oral suspension for cats
NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA Veraflox 25 mg/ml peroralna suspenzija za mačke
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Aluminium blister of 7 tablets (15 mg)
OSNOVNI PODACI KOJI SE MORAJU NALAZITI NA BLISTERIMA ILI TRAKAMA Aluminijski blister (15 mg)
Do not use in dogs during pregnancy and lactation (see section 4.7).
Ne primjenjivati kod pasa tijekom gravidnosti i laktacije (vidi odjeljak 4.7).
Do not use in cats during pregnancy and lactation (see section 4.7).
Ne primjenjivati kod mačaka tijekom gravidnosti i laktacije (vidi odjeljak 4.7).
PACKAGE SIZE - 15 ml bottle and a 3ml oral dosing syringe
VELIČINA PAKOVANJA 15 ml bočica polipropilenska šprica za peroralno doziranje od 3 ml
Staphylococcus intermedius group (including S. pseudintermedius)
Staphylococcus intermedius skupina (uključujući S. pseudintermedius)
Use of the veterinary medicinal product deviating from instructions given in the summary of product characteristics (SPC) may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other fluoroquinolones due to the potential for crossresistance.
Primjena veterinarsko-medicinskih proizvoda koja odstupa od uputa navedenih u sažetku opisa svojstava (SPC) može povećati prevalenciju bakterija otpornih na fluorokinolone i može smanjiti djelotvornost liječenja s drugim fluorokinolonima uslijed potencijalne unakrsne otpornosti.
Lactation:
Predoziranje:
Do not use in dogs with central nervous system (CNS) disorders, such as epilepsy, as fluoroquinolones could possibly cause seizures in predisposed animals.
Ne primjenjivati kod pasa s poremećajima središnjeg živčanog sustava (CNS), kao što su epilepsija, jer fluorokinoloni mogu eventualno izazvati napadaje kod predisponiranih životinja.
The recommended dose is 3 mg/kg bodyweight of pradofloxacin once daily according to the following tables.
Preporučena doza iznosi 3 mg/kg tjelesne mase pradofloksacina jednom dnevno.
The safety of this veterinary medicinal product has not been established during pregnancy and lactation.
Neškodljivost veterinarsko-medicinskog proizvoda nije utvrđena kod mačaka za vrijeme graviditeta i laktacije.
NAME OF THE VETERINARY MEDICINAL PRODUCT Veraflox 15 mg tablets for dogs and cats pradofloxacin
NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA Veraflox 15 mg tablete za pse i mačke pradofloksacin
Do not use in cats with central nervous system (CNS) disorders, such as epilepsy, as fluoroquinolones could potentially cause seizures in predisposed animals.
Ne primjenjivati kod mačaka s poremećajima središnjeg živčanog sustava (CNS), kao što su epilepsija, jer fluorokinoloni mogu eventualno izazvati napadaje kod predisponiranih životinja.
The safety of Veraflox has not been established during pregnancy and lactation in dogs.
Neškodljivost Verafloxa nije dokazana tijekom graviditeta i laktacije kod pasa i mačaka.
• acute infections of the upper respiratory tract caused by susceptible strains of Pasteurella multocida, Escherichia coli and the Staphylococcus intermedius group (including S. pseudintermedius).
• Akutne infekcije gornjih dišnih prohoda uzrokovane osjetljivim sojevima Pasteurella multocida, Escherichia coli i skupine Staphylococcus intermedius (uključujući S. pseudintermedius).
STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 60 mg pradofloxacin.
SASTAV DJELATNIH TVARI Svaka tableta sadržava 60 mg pradofloksacina.
Infections of the skin:
Infekcije rana i apscesi
STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 15 mg pradofloxacin.
SASTAV DJELATNIH TVARI Svaka tableta sadržava 15 mg pradofloksacina.
NAME OF THE VETERINARY MEDICINAL PRODUCT Veraflox 15 mg tablets for dogs and cats Veraflox 60 mg tablets for dogs Veraflox 120 mg tablets for dogs
NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA Veraflox 15mg tablete za pse i mačke Veraflox 60 mg tablete za pse
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) Oral suspension containing 25 mg/ml pradofloxacin Preservative: Sorbic acid (E200) 2 mg/ml
Peroralna suspenzija sadrži 25 mg/ml pradofloksacina Konzervans: sorbinska kiselina (E200) 2 mg/ml Žućkasta do bež suspenzija.
ROUTE(S) OF ADMINISTRATION Oral use.
PUT(EVI) PRIMJENE Peroralna primjena.
• wound infections and abscesses caused by susceptible strains of Pasteurella multocida and the
• Akutne infekcije gornjih dišnih prohoda uzrokovane osjetljivim sojevima Pasteurella multocida,
Treatment of: • acute infections of the upper respiratory tract caused by susceptible strains of Pasteurella multocida, Escherichia coli and the Staphylococcus intermedius group (including S. pseudintermedius).
Liječenje akutnih infekcija gornjih dišnih prohoda uzrokovanih osjetljivim sojevima Pasteurella multocida, Escherichia coli i skupine Staphylococcus intermedius (uključujući S. pseudintermedius).